| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |